Please sign in to follow a disease.

Ovarian neoplasm

Clinical trials for Ovarian neoplasm explained in plain language.

Never miss a new study

Get alerted when new Ovarian neoplasm trials appear

Sign up with your email to follow new studies for Ovarian neoplasm, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New drug BT8009 targets Hard-to-Treat cancers in early trial

Disease control Ongoing

This study tests a new drug called BT8009, alone or with another drug (pembrolizumab), in people with advanced solid tumors like bladder, breast, lung, or ovarian cancer. The drug targets a protein called Nectin-4 found on some cancer cells. The trial aims to find safe doses and …

Matched conditions: OVARIAN NEOPLASM

Phase 1/2 • Sponsor: BicycleTx Limited • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

Ovarian neoplasm

Get alerted when new Ovarian neoplasm trials appear

New drug BT8009 targets Hard-to-Treat cancers in early trial